Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysisStuart D. Cook, Elke Sylvester, Thomas Leist et al.|Multiple Sclerosis and Related Disorders|2018Cited by 122
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trialBianca Weinstock‐Guttman, Jerry S. Wolinsky, Thomas Leist et al.|Multiple Sclerosis Journal|2021Cited by 23